MeVPMe12 (R), n=2 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: ACh

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 408.5 23.5 1168.5 664.0 94.0 289.5 436.0 38.0 4.5 79.5 3206
1 113.5 0.5 617.0 148.5 8.5 52.0 54.5 1.5 - 14.0 1010
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 349
1 12
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 34.5
1 9.5

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 6412

Number of pre synapses: 2020

Number of output connections: 4892

Coverage factor: 1.6

Columnar completeness: 0.86

Area completeness: 0.92

Cell size (columns): 619

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVPMe12 (R) % % cumu.
0 Mi9 (R) Glu 1,083 541.5 15.1% 15.1%
1 Mi10 (R) ACh 1,077 538.5 15.0% 30.0%
2 Dm20 (R) Glu 662 331.0 9.2% 39.2%
3 aMe30 (R) Glu 461 230.5 6.4% 45.6%
4 TmY18 (R) ACh 406 203.0 5.6% 51.3%
5 aMe4 (R) ACh 283 141.5 3.9% 55.2%
6 MeVC3 (L) ACh 252 126.0 3.5% 58.7%
7 MeVC11 (L) ACh 189 94.5 2.6% 61.4%
8 aMe2 (R) Glu 182 91.0 2.5% 63.9%
9 aMe5 (R) ACh 172 86.0 2.4% 66.3%
10 Mi4 (R) GABA 170 85.0 2.4% 68.6%
11 Cm7 (R) Glu 149 74.5 2.1% 70.7%
12 MeVC4a (L) ACh 147 73.5 2.0% 72.8%
13 Tm39 (R) ACh 144 72.0 2.0% 74.8%
14 MeVC2 (L) ACh 120 60.0 1.7% 76.4%
15 aMe12 (R) ACh 117 58.5 1.6% 78.0%
16 aMe6b (R) ACh 76 38.0 1.1% 79.1%
17 MeVPMe12 (L) ACh 59 29.5 0.8% 79.9%
18 aMe6c (R) Glu 57 28.5 0.8% 80.7%
19 MeVC20 (R) Glu 56 28.0 0.8% 81.5%
20 Cm3 (R) GABA 55 27.5 0.8% 82.3%
21 MeVC24 (R) Glu 55 27.5 0.8% 83.0%
22 Dm9 (R) Glu 52 26.0 0.7% 83.7%
23 OA-AL2i3 (R) OA 52 26.0 0.7% 84.5%
24 MeVC23 (R) Glu 51 25.5 0.7% 85.2%
25 Cm21 (R) GABA 50 25.0 0.7% 85.9%
26 Dm2 (R) ACh 48 24.0 0.7% 86.5%
27 MeVPLo2 (R) ACh 44 22.0 0.6% 87.2%
28 L5 (R) ACh 41 20.5 0.6% 87.7%
29 Mi15 (R) ACh 37 18.5 0.5% 88.2%
30 MeVC4b (L) ACh 32 16.0 0.4% 88.7%
31 Lawf1 (R) ACh 24 12.0 0.3% 89.0%
32 Tm5c (R) Glu 24 12.0 0.3% 89.4%
33 aMe17c (R) Glu 20 10.0 0.3% 89.6%
34 R8p (R) His 20 10.0 0.3% 89.9%
35 l-LNv (L) unclear 19 9.5 0.3% 90.2%
36 l-LNv (R) unclear 18 9.0 0.3% 90.4%
37 R8y (R) His 18 9.0 0.3% 90.7%
38 T4d (R) ACh 18 9.0 0.3% 90.9%
39 Tm3 (R) ACh 17 8.5 0.2% 91.2%
40 MeVPMe12 (R) ACh 16 8.0 0.2% 91.4%
41 Cm11a (R) ACh 15 7.5 0.2% 91.6%
42 Dm-DRA1 (R) Glu 15 7.5 0.2% 91.8%
43 Cm31b (R) GABA 14 7.0 0.2% 92.0%
44 L3 (R) ACh 14 7.0 0.2% 92.2%
45 MeVC27 (L) unclear 14 7.0 0.2% 92.4%
46 Tm5b (R) ACh 14 7.0 0.2% 92.6%
47 Mi19 (R) 5HT 13 6.5 0.2% 92.8%
48 Dm10 (R) GABA 12 6.0 0.2% 92.9%
49 MeTu3c (R) ACh 12 6.0 0.2% 93.1%
50 aMe10 (L) ACh 11 5.5 0.2% 93.2%
51 Cm1 (R) ACh 11 5.5 0.2% 93.4%
52 Cm17 (R) GABA 11 5.5 0.2% 93.5%
53 Dm12 (R) Glu 11 5.5 0.2% 93.7%
54 Mi1 (R) ACh 10 5.0 0.1% 93.8%
55 Mi13 (R) Glu 10 5.0 0.1% 94.0%
56 OA-AL2i1 (R) OA 10 5.0 0.1% 94.1%
57 TmY3 (R) ACh 10 5.0 0.1% 94.3%
58 aMe26 (R) ACh 9 4.5 0.1% 94.4%
59 Cm5 (R) GABA 9 4.5 0.1% 94.5%
60 Dm4 (R) Glu 9 4.5 0.1% 94.6%
61 MeVP1 (R) ACh 9 4.5 0.1% 94.8%
62 T4b (R) ACh 9 4.5 0.1% 94.9%
63 5-HTPMPV03 (L) 5HT 8 4.0 0.1% 95.0%
64 MeTu3b (R) ACh 8 4.0 0.1% 95.1%
65 OA-AL2i4 (R) OA 8 4.0 0.1% 95.2%
66 Tm26 (R) ACh 8 4.0 0.1% 95.3%
67 TmY13 (R) ACh 8 4.0 0.1% 95.4%
68 aMe17a (R) Glu 7 3.5 0.1% 95.5%
69 Cm34 (R) Glu 7 3.5 0.1% 95.6%
70 MeLo3a (R) ACh 7 3.5 0.1% 95.7%
71 Tm12 (R) ACh 7 3.5 0.1% 95.8%
72 TmY10 (R) ACh 7 3.5 0.1% 95.9%
73 5-HTPMPV03 (R) 5HT 6 3.0 0.1% 96.0%
74 Li20 (R) Glu 6 3.0 0.1% 96.1%
75 MeLo3b (R) ACh 6 3.0 0.1% 96.2%
76 MeVPMe13 (R) ACh 6 3.0 0.1% 96.3%
77 Mi20 (R) Glu 6 3.0 0.1% 96.3%
78 C3 (R) GABA 5 2.5 0.1% 96.4%
79 Cm30 (R) GABA 5 2.5 0.1% 96.5%
80 Cm35 (R) GABA 5 2.5 0.1% 96.6%
81 DNc01 (R) unclear 5 2.5 0.1% 96.6%
82 MeTu1 (R) ACh 5 2.5 0.1% 96.7%
83 MeVCMe1 (R) ACh 5 2.5 0.1% 96.8%
84 MeVP12 (R) ACh 5 2.5 0.1% 96.8%
85 MeVP8 (R) ACh 5 2.5 0.1% 96.9%
86 Tm2 (R) ACh 5 2.5 0.1% 97.0%
87 Tm20 (R) ACh 5 2.5 0.1% 97.0%
88 Cm14 (R) GABA 4 2.0 0.1% 97.1%
89 Cm28 (R) unclear 4 2.0 0.1% 97.2%
90 Dm14 (R) Glu 4 2.0 0.1% 97.2%
91 Dm16 (R) Glu 4 2.0 0.1% 97.3%
92 LC14b (L) ACh 4 2.0 0.1% 97.3%
93 MeTu4a (R) ACh 4 2.0 0.1% 97.4%
94 Mi18 (R) GABA 4 2.0 0.1% 97.4%
95 Tm37 (R) Glu 4 2.0 0.1% 97.5%
96 aMe12 (L) ACh 3 1.5 0.0% 97.5%
97 Cm16 (R) Glu 3 1.5 0.0% 97.6%
98 Dm11 (R) Glu 3 1.5 0.0% 97.6%
99 Dm6 (R) Glu 3 1.5 0.0% 97.7%
100 DNc02 (R) unclear 3 1.5 0.0% 97.7%
101 MeLo14 (R) Glu 3 1.5 0.0% 97.7%
102 MeLo4 (R) ACh 3 1.5 0.0% 97.8%
103 MeVC10 (L) ACh 3 1.5 0.0% 97.8%
104 MeVC22 (R) Glu 3 1.5 0.0% 97.9%
105 MeVC26 (L) ACh 3 1.5 0.0% 97.9%
106 MeVP32 (R) ACh 3 1.5 0.0% 97.9%
107 MeVP7 (R) ACh 3 1.5 0.0% 98.0%
108 MeVPMe4 (L) Glu 3 1.5 0.0% 98.0%
109 MeVPMe4 (R) Glu 3 1.5 0.0% 98.1%
110 MeVPMe6 (L) Glu 3 1.5 0.0% 98.1%
111 Tm29 (R) Glu 3 1.5 0.0% 98.2%
112 Cm-DRA (R) ACh 2 1.0 0.0% 98.2%
113 Cm10 (R) GABA 2 1.0 0.0% 98.2%
114 Cm22 (R) GABA 2 1.0 0.0% 98.2%
115 Cm23 (R) Glu 2 1.0 0.0% 98.3%
116 Cm25 (R) Glu 2 1.0 0.0% 98.3%
117 Cm6 (R) GABA 2 1.0 0.0% 98.3%
118 Cm8 (R) GABA 2 1.0 0.0% 98.3%
119 Cm9 (R) Glu 2 1.0 0.0% 98.4%
120 Cm_unclear (R) ACh 2 1.0 0.0% 98.4%
121 CT1 (L) GABA 2 1.0 0.0% 98.4%
122 Lat3 (R) unclear 2 1.0 0.0% 98.5%
123 MeLo1 (R) ACh 2 1.0 0.0% 98.5%
124 MeLo6 (R) ACh 2 1.0 0.0% 98.5%
125 MeLo7 (R) ACh 2 1.0 0.0% 98.5%
126 MeVC1 (L) ACh 2 1.0 0.0% 98.6%
127 MeVC9 (L) ACh 2 1.0 0.0% 98.6%
128 MeVP11 (R) ACh 2 1.0 0.0% 98.6%
129 MeVP14 (R) ACh 2 1.0 0.0% 98.7%
130 MeVP47 (R) unclear 2 1.0 0.0% 98.7%
131 MeVP5 (R) unclear 2 1.0 0.0% 98.7%
132 MeVP9 (R) ACh 2 1.0 0.0% 98.7%
133 MeVPMe13 (L) ACh 2 1.0 0.0% 98.8%
134 MeVPMe7 (L) Glu 2 1.0 0.0% 98.8%
135 Mi14 (R) Glu 2 1.0 0.0% 98.8%
136 Mi16 (R) GABA 2 1.0 0.0% 98.8%
137 T2 (R) ACh 2 1.0 0.0% 98.9%
138 Tm1 (R) ACh 2 1.0 0.0% 98.9%
139 Tm16 (R) ACh 2 1.0 0.0% 98.9%
140 Tm31 (R) Glu 2 1.0 0.0% 99.0%
141 Tm32 (R) Glu 2 1.0 0.0% 99.0%
142 Tm34 (R) Glu 2 1.0 0.0% 99.0%
143 Tm4 (R) ACh 2 1.0 0.0% 99.0%
144 TmY17 (R) ACh 2 1.0 0.0% 99.1%

Outputs

  instance NT total connections connections /#MeVPMe12 (R) % % cumu.
0 Lawf1 (R) ACh 3,502 1,751.0 69.7% 69.7%
1 Tm5c (R) Glu 377 188.5 7.5% 77.2%
2 l-LNv (R) unclear 98 49.0 2.0% 79.2%
3 Mi19 (R) 5HT 96 48.0 1.9% 81.1%
4 MeVC20 (R) Glu 68 34.0 1.4% 82.4%
5 Mi14 (R) Glu 66 33.0 1.3% 83.8%
6 aMe4 (R) ACh 47 23.5 0.9% 84.7%
7 Mi9 (R) Glu 44 22.0 0.9% 85.6%
8 aMe12 (R) ACh 41 20.5 0.8% 86.4%
9 Dm9 (R) Glu 32 16.0 0.6% 87.0%
10 Pm8 (R) GABA 29 14.5 0.6% 87.6%
11 Mi10 (R) ACh 27 13.5 0.5% 88.1%
12 Cm5 (R) GABA 26 13.0 0.5% 88.7%
13 MeVP21 (R) ACh 20 10.0 0.4% 89.1%
14 Cm11a (R) ACh 19 9.5 0.4% 89.4%
15 Cm11c (R) ACh 18 9.0 0.4% 89.8%
16 Dm2 (R) ACh 18 9.0 0.4% 90.1%
17 MeTu3c (R) ACh 18 9.0 0.4% 90.5%
18 Cm21 (R) GABA 17 8.5 0.3% 90.8%
19 MeVPMe12 (R) ACh 16 8.0 0.3% 91.2%
20 MeLo1 (R) ACh 13 6.5 0.3% 91.4%
21 Mi16 (R) GABA 13 6.5 0.3% 91.7%
22 Cm6 (R) GABA 12 6.0 0.2% 91.9%
23 Mi15 (R) ACh 12 6.0 0.2% 92.2%
24 CT1 (L) GABA 11 5.5 0.2% 92.4%
25 MeVP11 (R) ACh 11 5.5 0.2% 92.6%
26 MeVPMe13 (R) ACh 11 5.5 0.2% 92.8%
27 Cm11b (R) ACh 10 5.0 0.2% 93.0%
28 Tm20 (R) ACh 10 5.0 0.2% 93.2%
29 Dm10 (R) GABA 9 4.5 0.2% 93.4%
30 MeLo3a (R) ACh 9 4.5 0.2% 93.6%
31 aMe5 (R) ACh 8 4.0 0.2% 93.7%
32 Cm11d (R) ACh 8 4.0 0.2% 93.9%
33 Cm28 (R) unclear 8 4.0 0.2% 94.0%
34 Cm31b (R) GABA 8 4.0 0.2% 94.2%
35 Mi4 (R) GABA 8 4.0 0.2% 94.4%
36 TmY5a (R) Glu 8 4.0 0.2% 94.5%
37 Cm17 (R) GABA 7 3.5 0.1% 94.7%
38 MeVP40 (R) unclear 7 3.5 0.1% 94.8%
39 TmY18 (R) ACh 7 3.5 0.1% 94.9%
40 MeTu3b (R) ACh 6 3.0 0.1% 95.1%
41 Tm4 (R) ACh 6 3.0 0.1% 95.2%
42 TmY10 (R) ACh 6 3.0 0.1% 95.3%
43 TmY15 (R) GABA 6 3.0 0.1% 95.4%
44 Cm10 (R) GABA 5 2.5 0.1% 95.5%
45 Dm12 (R) Glu 5 2.5 0.1% 95.6%
46 l-LNv (L) unclear 5 2.5 0.1% 95.7%
47 MeLo2 (R) ACh 5 2.5 0.1% 95.8%
48 MeLo3b (R) ACh 5 2.5 0.1% 95.9%
49 MeTu4c (R) ACh 5 2.5 0.1% 96.0%
50 Tm9 (R) ACh 5 2.5 0.1% 96.1%
51 aMe3 (R) Glu 4 2.0 0.1% 96.2%
52 aMe30 (R) Glu 4 2.0 0.1% 96.3%
53 Cm3 (R) GABA 4 2.0 0.1% 96.4%
54 Dm20 (R) Glu 4 2.0 0.1% 96.4%
55 MeVP6 (R) Glu 4 2.0 0.1% 96.5%
56 Mi18 (R) GABA 4 2.0 0.1% 96.6%
57 Mi2 (R) Glu 4 2.0 0.1% 96.7%
58 T4b (R) ACh 4 2.0 0.1% 96.8%
59 Tm12 (R) ACh 4 2.0 0.1% 96.8%
60 Tm37 (R) Glu 4 2.0 0.1% 96.9%
61 Tm5b (R) ACh 4 2.0 0.1% 97.0%
62 Tm5Y (R) ACh 4 2.0 0.1% 97.1%
63 5-HTPMPV03 (L) 5HT 3 1.5 0.1% 97.1%
64 Cm22 (R) GABA 3 1.5 0.1% 97.2%
65 Cm7 (R) Glu 3 1.5 0.1% 97.3%
66 Dm16 (R) Glu 3 1.5 0.1% 97.3%
67 Lawf2 (R) ACh 3 1.5 0.1% 97.4%
68 MeVC27 (L) unclear 3 1.5 0.1% 97.4%
69 MeVP1 (R) ACh 3 1.5 0.1% 97.5%
70 MeVPMe2 (R) Glu 3 1.5 0.1% 97.6%
71 Mi1 (R) ACh 3 1.5 0.1% 97.6%
72 OA-AL2i3 (R) OA 3 1.5 0.1% 97.7%
73 SLP249 (R) unclear 3 1.5 0.1% 97.7%
74 Tm36 (R) ACh 3 1.5 0.1% 97.8%
75 TmY13 (R) ACh 3 1.5 0.1% 97.8%
76 aMe2 (R) Glu 2 1.0 0.0% 97.9%
77 aMe26 (R) ACh 2 1.0 0.0% 97.9%
78 C2 (R) GABA 2 1.0 0.0% 98.0%
79 Cm-DRA (R) ACh 2 1.0 0.0% 98.0%
80 Cm20 (R) GABA 2 1.0 0.0% 98.0%
81 Cm24 (R) Glu 2 1.0 0.0% 98.1%
82 Cm8 (R) GABA 2 1.0 0.0% 98.1%
83 Dm4 (R) Glu 2 1.0 0.0% 98.2%
84 DNc02 (R) unclear 2 1.0 0.0% 98.2%
85 L3 (R) ACh 2 1.0 0.0% 98.2%
86 MeTu3a (R) ACh 2 1.0 0.0% 98.3%
87 MeVC23 (R) Glu 2 1.0 0.0% 98.3%
88 MeVC3 (L) ACh 2 1.0 0.0% 98.4%
89 MeVP12 (R) ACh 2 1.0 0.0% 98.4%
90 MeVP29 (R) ACh 2 1.0 0.0% 98.4%
91 MeVP32 (R) ACh 2 1.0 0.0% 98.5%
92 MeVP33 (R) ACh 2 1.0 0.0% 98.5%
93 MeVP36 (R) unclear 2 1.0 0.0% 98.6%
94 MeVPLo2 (R) ACh 2 1.0 0.0% 98.6%
95 MeVPMe12 (L) ACh 2 1.0 0.0% 98.6%
96 MeVPMe13 (L) ACh 2 1.0 0.0% 98.7%
97 MeVPMe4 (R) Glu 2 1.0 0.0% 98.7%
98 Pm3 (R) GABA 2 1.0 0.0% 98.8%
99 R7p (R) His 2 1.0 0.0% 98.8%
100 R8p (R) His 2 1.0 0.0% 98.8%
101 T4d (R) ACh 2 1.0 0.0% 98.9%
102 Tm38 (R) ACh 2 1.0 0.0% 98.9%
103 TmY17 (R) ACh 2 1.0 0.0% 99.0%
104 TmY3 (R) ACh 2 1.0 0.0% 99.0%